# Kiyatec

Source: https://onco.cc/companies/kiyatec/  
OnCo record `kiyatec` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Kiyatec grows a patient's tumour cells in 3D culture and tests drugs on them, with a focus on ovarian, breast, glioblastoma and rare tumours.

## Summary

Kiyatec's ex vivo 3D cell culture platform predicts which drugs a patient's tumour will respond to by exposing living tumour cells to candidate therapies, and it has published clinical correlation studies in glioblastoma and ovarian cancer. Physician-ordered.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor; fcct-directory
- HQ: United States (city not published)
- Type: diagnostics
- Website: https://kiyatec.com/

## Sources

- Official website: https://kiyatec.com/
- Listed on Future of Cancer Care Today (Sijbrandij Foundation): https://sijbrandijfoundation.org/fcct

## Connected records

- cancers: [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Ovarian cancer](https://onco.cc/cancers/ovarian/)
- technologies: [Functional (ex vivo) drug testing](https://onco.cc/technologies/functional-drug-testing/), [Patient-derived organoids](https://onco.cc/technologies/organoids/)

---
JSON: https://onco.cc/api/v1/entities/kiyatec.json